1. Home
  2. MGLD vs PDSB Comparison

MGLD vs PDSB Comparison

Compare MGLD & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • PDSB
  • Stock Information
  • Founded
  • MGLD 1996
  • PDSB 2005
  • Country
  • MGLD United States
  • PDSB United States
  • Employees
  • MGLD N/A
  • PDSB N/A
  • Industry
  • MGLD Finance/Investors Services
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGLD Finance
  • PDSB Health Care
  • Exchange
  • MGLD Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • MGLD 44.8M
  • PDSB 44.5M
  • IPO Year
  • MGLD N/A
  • PDSB N/A
  • Fundamental
  • Price
  • MGLD $1.01
  • PDSB $0.93
  • Analyst Decision
  • MGLD
  • PDSB Strong Buy
  • Analyst Count
  • MGLD 0
  • PDSB 2
  • Target Price
  • MGLD N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • MGLD 4.7K
  • PDSB 473.0K
  • Earning Date
  • MGLD 11-07-2025
  • PDSB 11-13-2025
  • Dividend Yield
  • MGLD N/A
  • PDSB N/A
  • EPS Growth
  • MGLD N/A
  • PDSB N/A
  • EPS
  • MGLD N/A
  • PDSB N/A
  • Revenue
  • MGLD $30,154,000.00
  • PDSB N/A
  • Revenue This Year
  • MGLD N/A
  • PDSB N/A
  • Revenue Next Year
  • MGLD N/A
  • PDSB N/A
  • P/E Ratio
  • MGLD N/A
  • PDSB N/A
  • Revenue Growth
  • MGLD N/A
  • PDSB N/A
  • 52 Week Low
  • MGLD $0.64
  • PDSB $0.85
  • 52 Week High
  • MGLD $2.10
  • PDSB $3.48
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 46.70
  • PDSB 35.69
  • Support Level
  • MGLD $1.03
  • PDSB $0.90
  • Resistance Level
  • MGLD $1.08
  • PDSB $1.02
  • Average True Range (ATR)
  • MGLD 0.05
  • PDSB 0.06
  • MACD
  • MGLD -0.01
  • PDSB 0.00
  • Stochastic Oscillator
  • MGLD 12.21
  • PDSB 20.56

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: